NDC 69336-129
Esomeprazole strontium
Esomeprazole Strontium
Esomeprazole strontium is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Sterling-knight Pharmaceuticals, Llc. The primary component is Esomeprazole Strontium.
| Product ID | 69336-129_efe4b937-3708-4288-a6ae-8cb189ab0055 |
| NDC | 69336-129 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Esomeprazole strontium |
| Generic Name | Esomeprazole Strontium |
| Dosage Form | Capsule, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-06-25 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA202342 |
| Labeler Name | Sterling-Knight Pharmaceuticals, LLC |
| Substance Name | ESOMEPRAZOLE STRONTIUM |
| Active Ingredient Strength | 49 mg/1 |
| Pharm Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |